Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Net income	$ 862	$ 777	$ 2,544	$ 2,413
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization			571	482
Provision for loan losses				202
Amortization of premium on securities, net			440	438
Gains on sales of loans held for sale			(407)	(106)
Losses (gains) on sales and writedowns of other real estate, net	140		140	(5)
Gains on sales of investment securities	(12)		(52)	(108)
Increase in value of life insurance contracts			(120)	(77)
Stock compensation expense			102	41
Originations of loans held for sale			(18,136)	(6,400)
Proceeds from sales of loans held for sale			18,391	6,189
Changes in assets and liabilities:
Accrued income			51	100
Other assets			(154)	(47)
Deferred taxes, net			11	603
Accrued interest payable			167	9
Other liabilities			(686)	589
Net cash flows provided by operating activities			2,862	4,323
Cash flows used in investing activities:
Net (increase) decrease in federal funds sold			(1,026)	627
Purchases of investment securities available for sale			(5,997)	(6,438)
Sales, maturities, and calls of available for sale securities			9,494	8,710
Purchase of restricted equity securities, net			(218)	(13)
Net increase in loans			(28,500)	(23,352)
Proceeds from sales of other real estate			138	982
Purchases of bank owned life insurance			(2,500)
Purchases of property and equipment			(329)	(1,863)
Net cash flows used in investing activities			(28,938)	(21,347)
Cash flows from financing activities:
Net increase in noninterest-bearing deposits			30,224	947
Net increase in interest-bearing deposits			7,408	10,760
Net increase in FHLB borrowings			4,900	250
Net increase in other borrowings			439	211
Net increase in equity of non-controlling interest			317
Preferred stock dividend payment			(630)	(630)
Net cash flows provided by financing activities			42,658	11,538
Net increase (decrease) in cash and cash equivalents			16,582	(5,486)
Cash and cash equivalents, beginning			13,795	19,537	$ 19,537
Cash and cash equivalents, ending	$ 30,377	$ 14,051	30,377	14,051	$ 13,795
Supplemental disclosure of cash flow information:
Cash payments for interest			1,530	1,585
Cash payments for income taxes			1,676	42
Supplemental disclosure of noncash investing activities:
Change in unrealized gains on available for sale securities			$ (32)	1,342
Transfer from loans to other real estate				$ 1,520